CG Oncology, Inc. Common stock
Stock Forecast, Prediction & Price Target
CG Oncology, Inc. Common stock (CGON) stock Price Target by analysts
CG Oncology, Inc. Common stock (CGON) stock Price Target by analysts
Average Price Target
$62.33
Potential upside: 143.87%
CG Oncology, Inc. Common stock price prediction
What is CG Oncology, Inc. Common stock stock analysts` prediction?
CG Oncology, Inc. Common stock stock forecast: Based on 3 Wall Street analysts` predicted price targets for CG Oncology, Inc. Common stock in the last 3 months, the avarage price target is $62.33, with a high forecast of $NaN. The average price target represents a 143.87% change from the last price of $25.56.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
CG Oncology, Inc. Common stock stock Price Target by analysts
Full breakdown of analysts given CG Oncology, Inc. Common stock price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Dai UBS | 0% 0/1 | 11 months ago | $60 134.74% upside | $35.61 | StreetInsider | Previous targets (0) |
Andres Maldonado H.C. Wainwright | 0% 0/1 | 12 months ago | $75 193.42% upside | $37.94 | StreetInsider | Previous targets (0) |
Corinne Johnson Goldman Sachs | 0% 0/2 | 12 months ago | $52 103.44% upside | $34.8 | StreetInsider | Previous targets (1) |
Corinne Johnson Goldman Sachs | 0% 0/2 | over 1 year ago | $50 95.61% upside | $25.84 | TheFly | Previous targets (1) |
FAQ
What is the best performing analyst?
In the last twelve months 3 analysts have been covering CG Oncology, Inc. Common stock stock. The most successful analyst is David Dai.